Somaxon Pharmaceuticals, Inc.
Overview
Somaxon Pharmaceuticals, Inc. was a specialty pharmaceutical company focused on the in-licensing, development, and commercialization of proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system. The company was primarily known for its insomnia drug Silenor.
Therapeutic areas
Central Nervous SystemInsomnia
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Somaxon Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.